BLTE (Belite Bio, Inc) Stock Financials & Earnings | Market Cap Arena

BLTE (Belite Bio, Inc) Stock Financials & Earnings | Market Cap Arena

BLTEBelite Bio, Inc

Mkt Cap$7B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$78M

EPS (TTM)-$2.31

Free Cash Flow (TTM)$0

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$7M
Q2 23	$0	$0	-$7M
Q3 23	$0	$0	-$11M
Q4 23	$0	$0	-$7M
Q1 24	$0	$0	-$8M
Q2 24	$0	$0	-$10M
Q3 24	$0	$0	-$10M
Q4 24	$0	$0	-$11M
Q1 25	$0	$0	-$16M
Q2 25	$0	$0	-$18M
Q3 25	$0	$0	-$23M
Q4 25	$0	$0	-$28M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 22	$741	$741
Q4 22	-$6M	-$6M
Q1 23	$0	$0
Q2 23	$0	$0
Q3 23	$0	$0
Q4 23	$0	$0
Q1 24	$0	$0
Q2 24	$0	$0
Q3 24	$0	$0
Q4 24	$0	$0
Q1 25	$0	$0
Q2 25	$0	$0

Capital Expenditures

CapEx

Quarter	CapEx
Q3 22	$0
Q4 22	$56K
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+553.5%
Q2 23	—	+174.2%
Q3 23	—	+331.5%
Q4 23	—	+3.5%
Q1 24	—	+21.0%
Q2 24	—	+52.4%
Q3 24	—	-11.1%
Q4 24	—	+64.7%
Q1 25	—	+86.3%
Q2 25	—	+68.0%
Q3 25	—	+136.3%
Q4 25	—	+145.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 22	$741	—
Q4 22	$1K	—
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$4K	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$0	—
Q4 24	$9K	—
Q1 25	$0	—
Q2 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$6M	$1M
Q2 23	$6M	$1M
Q3 23	$9M	$2M
Q4 23	$5M	$2M
Q1 24	$7M	$2M
Q2 24	$9M	$1M
Q3 24	$7M	$3M
Q4 24	$7M	$4M
Q1 25	$9M	$6M
Q2 25	$11M	$7M
Q3 25	$10M	$13M
Q4 25	$15M	$13M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$42M	$0	$42M
Q1 23	$38M	$0	$38M
Q2 23	$57M	$0	$57M
Q3 23	$55M	$0	$55M
Q4 23	$88M	$0	$88M
Q1 24	$96M	$0	$96M
Q2 24	$96M	$0	$96M
Q3 24	$0	$0	$0
Q4 24	$32M	$113M	$145M
Q1 25	$0	$0	$0
Q2 25	$0	$0	$0
Q3 25	$157M	$119M	$276M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	21M	-6.6%
Q2 23	26M	+23.1%
Q3 23	27M	+5.9%
Q4 23	28M	+3.7%
Q1 24	30M	+4.8%
Q2 24	30M	+2.2%
Q3 24	31M	+1.2%
Q4 24	31M	+2.5%
Q1 25	32M	+2.0%
Q2 25	33M	+1.6%
Q3 25	33M	+2.0%
Q4 25	34M	+0.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	—	—
FY 21	—	—
FY 22	$0	16
FY 23	$0	20
FY 24	$0	25
FY 25	$0	25